Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants

NCT05134337 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: LOXO-305
DRUG: Itraconazole
DRUG: Rifampin

Sponsor

Loxo Oncology, Inc.